Prevalence and correlates of substance use and associations with HIV-related outcomes among trans women in the San Francisco Bay Area

BMC Infect Dis. 2022 Nov 26;22(1):886. doi: 10.1186/s12879-022-07868-4.

Abstract

Background: Trans women face tremendous social inequities as well as disproportionate rates of HIV and substance use, yet disaggregated substance use data specific to trans women remain limited.

Methods: We conducted a secondary analysis of baseline data from the Trans*National Study (2016-2017) surveying trans women in the San Francisco Bay Area (n = 629). Multivariable logistic regression was used to analyze socio-demographic and environmental correlates of substance use, and bivariate associations between substance use and HIV-associated outcomes are presented alongside prevalence data.

Results: Over half (52.9%) reported using substances in the prior year, most frequently marijuana, methamphetamine, and crack/cocaine. Those with unmet gender-affirming health care needs, lack of insurance, or a history of experiencing racial violence, transphobic violence, adult housing instability, or extreme poverty had higher odds of substance use. Sex work and condomless anal sex were also independently associated with substance use.

Conclusions: Among this sample of trans women, substance use and substance use concurrent with sex were highly prevalent, and associated with a number of socioeconomic and health care needs. These findings corroborate the need for holistic and intersectional efforts to reduce substance use and HIV risk.

Keywords: Discrimination; HIV; Social determinants of health; Substance use; Transgender persons.

MeSH terms

  • Adult
  • Female
  • HIV Infections* / complications
  • HIV Infections* / epidemiology
  • Humans
  • Prevalence
  • San Francisco / epidemiology
  • Substance-Related Disorders* / complications
  • Substance-Related Disorders* / epidemiology
  • Unsafe Sex